LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 65.30 | 56.33 | 1450 | 7570 | 0.1929 | 0.5018 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 67.00 | 56.33 | 1496 | 7731 | 0.1951 | 0.5077 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 68.70 | 56.33 | 1555 | 7933 | 0.1975 | 0.5136 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 70.50 | 56.33 | 1593 | 7990 | 0.2015 | 0.5131 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 72.20 | 56.33 | 1663 | 8053 | 0.2086 | 0.5233 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 73.90 | 56.33 | 1702 | 8150 | 0.2109 | 0.5238 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 75.60 | 56.33 | 1777 | 7992 | 0.2236 | 0.5381 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 77.30 | 56.33 | 1851 | 8135 | 0.2294 | 0.5441 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 79.00 | 56.33 | 1905 | 8048 | 0.2384 | 0.5509 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.70 | 56.33 | 1972 | 7920 | 0.2502 | 0.5596 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.40 | 56.33 | 2023 | 7810 | 0.2593 | 0.5615 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.10 | 56.33 | 2093 | 7655 | 0.2734 | 0.5753 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 85.80 | 56.33 | 2148 | 7583 | 0.2830 | 0.5777 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 87.50 | 56.33 | 2208 | 7334 | 0.3005 | 0.5903 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 89.20 | 56.33 | 2274 | 7229 | 0.3139 | 0.6001 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 90.90 | 56.33 | 2337 | 7174 | 0.3250 | 0.6071 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 92.60 | 56.33 | 2394 | 7065 | 0.3383 | 0.6158 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 94.30 | 56.33 | 2438 | 6924 | 0.3518 | 0.6162 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 95.70 | 27.76 | 2236 | 6712 | 0.3331 | 0.6154 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 2.30 | 56.33 | 252 | 255 | 0.9965 | 0.4568 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 4.00 | 56.33 | 308 | 303 | 1.0190 | 0.4475 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 5.70 | 56.33 | 350 | 342 | 1.0274 | 0.4333 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 7.40 | 56.33 | 385 | 385 | 1.0041 | 0.4262 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 9.10 | 56.33 | 406 | 424 | 0.9625 | 0.4073 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 10.80 | 56.33 | 435 | 465 | 0.9391 | 0.4454 |